Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kim, Jacob S."'
Autor:
Ellson, Christian D., Riça, Ingred Goretti, Kim, Jacob S., Huang, Yu-ming M, Lim, Daniel, Mitra, Tanya, Hsu, Albert, Wei, Erin X., Barrett, Christopher D., Otterbein, Leo E., Hauser, Carl J., Wahl, Martin, Delbrück, Heinrich, Heinemann, Udo, Oschkinat, Hartmut, Chang, Chia-en A., Yaffe, Michael B.
Publikováno v:
In Journal of Molecular Biology 15 May 2022 434(9)
Autor:
Zhu, Eric F., Gai, Shuning A., Opel, Cary F., Kwan, Byron H., Surana, Rishi, Mihm, Martin C., Kauke, Monique J., Moynihan, Kelly D., Angelini, Alessandro, Williams, Robert T., Stephan, Matthias T., Kim, Jacob S., Yaffe, Michael B., Irvine, Darrell J., Weiner, Louis M., Dranoff, Glenn, Wittrup, K. Dane
Publikováno v:
In Cancer Cell 13 April 2015 27(4):489-501
Autor:
Reinhardt, H. Christian, Kim, Jacob S., Ruf, Daniela M., Mitra, Tanya, Couvillon, Anthony D., Yaffe, Michael B., Cannell, Ian Gordon, Morandell, Sandra M., Jacks, Tyler E, Yaffe, Michael B
Publikováno v:
Elsevier
Cell Reports, Vol 5, Iss 4, Pp 868-877 (2013)
Cell Reports, Vol 5, Iss 4, Pp 868-877 (2013)
A fundamental limitation in devising new therapeutic strategies for killing cancer cells with DNA damaging agents is the need to identify synthetic lethal interactions between tumor-specific mutations and components of the DNA damage response (DDR) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19e0e1de42d9f06e526ce7f11329717d
https://pubmed.ncbi.nlm.nih.gov/24300879
https://pubmed.ncbi.nlm.nih.gov/24300879
Autor:
Morandell, Sandra, Reinhardt, H. Christian, Cannell, Ian G., Kim, Jacob S., Ruf, Daniela M., Mitra, Tanya, Couvillon, Anthony D., Jacks, Tyler, Yaffe, Michael B.
Publikováno v:
In Cell Reports 27 November 2013 5(4):868-877
Autor:
Matthias Stephan, Monique J. Kauke, Eric F. Zhu, Alessandro Angelini, Louis M. Weiner, Robert T. Williams, Kelly D. Moynihan, Jacob S. Kim, Byron Hua Kwan, Darrell J. Irvine, Michael B. Yaffe, K. Dane Wittrup, Glenn Dranoff, Rishi Surana, Martin C. Mihm, Cary F. Opel, Shuning A. Gai
Publikováno v:
PMC
Cancer immunotherapies under development have generally focused on either stimulating T cell immunity or driving antibody-directed effector functions of the innate immune system such as antibody-dependent cell-mediated cytotoxicity (ADCC). We find th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5eb98010bffc6a3a73f5f994e1e74f4